# ClinicalTrials.gov record NCT02025179

> PeptideScanner retained ClinicalTrials.gov record NCT02025179 at 2026-07-30T19:13:03.751Z. Its registry update date was 2023-05-10, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct02025179-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-05-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02025179-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02025179-teriparatide-v1.json
- Content SHA-256: `74ec33913688b8093bc8fa92f676c30f8fbc7a1f6db82b84458005d551a394a4`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02025179 ([`ctg-observation-nct02025179-2023-05-10-2ed52df8084f`](#source-ctg-observation-nct02025179-2023-05-10-2ed52df8084f))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02025179 at 2026-07-30T19:13:03.751Z. Its registry update date was 2023-05-10, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct02025179-2023-05-10-2ed52df8084f`](#source-ctg-observation-nct02025179-2023-05-10-2ed52df8084f))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02025179 at 2026-07-30T19:13:03.751Z. Its registry update date was 2023-05-10, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct02025179-2023-05-10-2ed52df8084f`](#source-ctg-observation-nct02025179-2023-05-10-2ed52df8084f))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02025179-2023-05-10-2ed52df8084f`](#source-ctg-observation-nct02025179-2023-05-10-2ed52df8084f))

## Sources

<a id="source-ctg-observation-nct02025179-2023-05-10-2ed52df8084f"></a>
- **ClinicalTrials.gov record NCT02025179 · retained source version 2023-05-10:2ed52df8084f0cb38420b216123c27d538a3209af435f6c4aa5b6e65884e00ec** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02025179) (`ctg-observation-nct02025179-2023-05-10-2ed52df8084f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02025179." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02025179-teriparatide-v1.json SHA-256: 74ec33913688b8093bc8fa92f676c30f8fbc7a1f6db82b84458005d551a394a4.